News

Filter

Current filters:

LyricaEli LillyPolitics

1 to 9 of 95920 results

Merck Serono starts building $105 million plant in Nantong, China

Merck Serono starts building $105 million plant in Nantong, China

27-08-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has started construction on its new pharmaceutical…

BiotechnologyChinaMerck KGaAMerck SeronoNantongPharmaceutical manufacturing facilityProduction

DPx Holdings acquires all shares of Gallus BioPharmaceuticals

27-08-2014

Privately-owned DPx Holdings has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals,…

Biologic and chemical drug substance developmentBiotechnologyContract manufacturingGallus BioPharmaceuticalsMergers & AcquisitionsPharmaceutical product development servicesPharmacologyUSA

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

Vifor’s Velphoro gains marketing authorization in the EU for hyperphosphatemia

27-08-2014

Switzerland-based iron deficiency specialist Vifor has received European Union marketing authorization…

Chronic kidney diseaseHyperphosphatemiaMedicineNephrologyNephrology and HepatologyPeritoneal dialysisPharmaceuticalRegulationRenal dialysisSwitzerlandVelphoroVifor Pharma

FDA backs added indication for GSK’s Promacta

FDA backs added indication for GSK’s Promacta

27-08-2014

The Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s supplemental New Drug…

GlaxoSmithKlineHematologyLigand PharmaceuticalsPharmaceuticalPromactaRare diseasesRegulationRevoladeUSA

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

Pfizer and Merck to explore potential of Xalkori/pembrolizumab combo

26-08-2014

US pharma giants Pfizer and Merck & Co have inked an agreement to explore the therapeutic potential of…

Merck & CoOncologypembrolizumabPfizerPharmaceuticalResearchXalkori

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

Health Canada OKs Biogen Idec’s hemophilia A therapy Eloctate

26-08-2014

Canadian regulator Health Canada has approved US Biotech major Biogen Idec’s Eloctate (antihemophilic…

Biogen IdecBiotechnologyCanadaEloctateHematologyRegulationSwedish Orphan Biovitrum

Recipharm inks deal with Isofol Medical on Modufolin

Recipharm inks deal with Isofol Medical on Modufolin

26-08-2014

Swedish contract development and manufacturing group Recipharm and Isofol Medical AB, a Gothenburg-based…

FinancialIsofol MedicalModufolinOncologyPharmaceuticalProductionRecipharmResearch

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

Concert Pharmaceuticals achieves $2 million milestone for its AVP-786

26-08-2014

USA-based Concert Pharmaceuticals has achieved a $2 million milestone under its development and license…

Avanir PharmaceuticalsAVP-786Concert PharmaceuticalsMajor depressive disorderMedicineNeurochemistryNeurologicalPharmaceuticalPharmacologyResearchTreatment of major depressive disorderUSA

1 to 9 of 95920 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top